LG CNS is making a big move into the pharmaceutical and biotech world. The IT branch of LG Group recently secured a massive government contract and finished a major automation project for a top drug manufacturer, signaling a shift in how the industry handles research and safety.
The company is now a lead player in the Ministry of Health and Welfare’s new drug development program. This project will invest about 37.1 billion won ($25.2 million) over the next four years to accelerate the discovery and testing of new medicines. LG CNS will build an AI platform that helps scientists design and manage clinical trials more efficiently.
Rather than using a single AI tool, the company uses “agentic AI.” This technology acts as a digital manager, coordinating multiple AI models. They are also using a technique called “federated learning.” This allows various hospitals to train AI models using their own data without ever sending sensitive patient information to outside servers. This method keeps data private while helping researchers move from the lab to clinical trials much faster.
Beyond government work, LG CNS recently helped the pharmaceutical firm Chong Kun Dang modernize its operations. They used their “AgenticWorks” platform to automate the Annual Product Quality Review. This task usually forces employees to spend weeks gathering data and writing manual reports.
LG CNS deployed 30 AI agents that work together. These agents pull data from different systems, analyze the numbers, and write final reports with just a few clicks. This new system cut the time needed for these reports by more than 90%. Because the AI handles the repetitive paperwork, staff can now spend their time on actual quality control and safety checks.
Kim Tae-hoon, a senior vice president at LG CNS, noted that both the government and private companies now recognize the value of their AI tech. He said the company wants to use these AI agents to make South Korea’s biotech industry more competitive. By handling complex data, LG CNS aims to transform how the industry researches and develops medicines.
